Is Disc Medicine Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Disc Medicine Inc (IRON) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Disc Medicine Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Disc Medicine Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Disc Medicine Inc?

Muslim investors may consider investing in Disc Medicine Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Disc Medicine Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Disc Medicine Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Disc Medicine Inc updated?

The Shariah compliance status of Disc Medicine Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Disc Medicine Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Disc Medicine Inc?

You can check the latest Shariah compliance status of Disc Medicine Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IRON Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 14, 2026

Report Source: 2026 1st Quarter Report

Disc Medicine Inc. Stock Analysis IRON

United States Health Care Mid Cap Report: Q1, 2026

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company is headquartered in Watertown, Massachusetts and currently employs 155 full-time employees. The company went IPO on 2020-08-12. The firm's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. The company is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Key Statistics of Disc Medicine Inc (IRON)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$66.48$71.18

Today's Open

$69.24

Volume

825.26K

P/E Ratio (TTM)

52 Week Range

$40.00$99.50

Market Cap

2.58B

Avg. Volume

443.20K

Dividend Yield

Financial Metrics & Statements of Disc Medicine Inc (IRON)

FAQ's for Disc Medicine Inc (IRON)

According to Musaffa’s Shariah screening methodology, Disc Medicine Inc (IRON) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.